BOTANICAL COMBINATION OF CURCUMIN AND COPTIS CHINESE FOR THE TREATMENT OF POST-DIVERTICULITS SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE: RESULTS OF A PHASE 1B STUDY

被引：0
|
作者：
Lahat, Adi
Salomon, Nir
Neuman, Sandra
Dvir, Revital
Farkash, Hadar
Kopylov, Uri
Ben-Horin, Shomron
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1350
引用
收藏
页码：S1035 / S1035
页数：1
相关论文
共 50 条
  • [41] Safety, pharmacokinetic and pharmacodynamic results from dose escalation of SAR439459, a TGFβ inhibitor, as monotherapy or in combination with cemiplimab in a phase 1/1b study.
    Williamson, Stephen K.
    Hodi, F. Stephen
    Johnson, Melissa Lynne
    Barve, Minal A.
    Juric, Dejan
    Baranda, Joaquina Celebre
    Schneider, Reva Elaine
    Bauer, Todd Michael
    Lin, Tun Tun
    Wang, Rui
    Amrate, Amele
    Guillemin-Paveau, Helene
    Sullivan, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Long-Term Results from a Phase 1b Study of Avadomide in Combination with Obinutuzumab in Patients with Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma
    Michot, Jean-Marie
    Bouabdallah, Reda
    Doorduijn, Jeanette K.
    Boccomini, Carola
    Kersten, Marie Jose
    Chiappella, Annalisa
    Zinzani, Pier Luigi
    Salles, Gilles
    Bijou, Fontanet
    Hentrup, Mei
    Rhee, So Hyun
    Hagner, Patrick
    Klein, Christian
    Pourdehnad, Michael
    Hege, Kristen
    Dobmeyer, Juergen
    Nikolova, Zariana
    Ribrag, Vincent
    BLOOD, 2020, 136
  • [43] Human Placenta-Derived Cells (PDA001) for the Treatment of Moderate-to-Severe Crohn's Disease: Results of a Phase 1b/2a Study
    Melmed, Gil
    Pandak, William
    Casey, Kevin
    Abraham, Bincy
    Valentine, John
    Schwartz, David
    Awais, Dahllia
    Lichtiger, Simon
    Bassan, Isaac
    Hanauer, Stephen
    Richards, Robert
    Oilonomou, Ioannis
    Parekh, Nimisha
    Targan, Stephan
    Johnson, Kristine
    Hariri, Robert
    Fischkoff, Steven
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S636 - S636
  • [44] Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study
    Deng, Rong
    Gibiansky, Leonid
    Lu, Tong
    Li, Xiaobin
    Lu, Dan
    Li, Chunze
    Girish, Sandhya
    Wang, Jue
    Boyer, Michelle
    Shankar, Noopur
    Humphrey, Kathryn
    Freise, Kevin J.
    Salem, Ahmed Hamed
    Seymour, John F.
    Kater, Arnon P.
    Miles, Dale
    LEUKEMIA & LYMPHOMA, 2020, 61 (01) : 56 - 65
  • [45] Results from a phase 1b study of blinatumomab-pembrolizumab combination in adults with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Giri, Pratyush
    Patil, Sushrut
    Ratnasingam, Sumita
    Prince, H. Miles
    Milliken, Samuel
    Meijide, Javier Briones
    Coyle, Luke
    Van der Poel, Marjolein
    Mulroney, Carolyn M.
    Farooqui, Mohammed Z. H.
    Wong, Hansen
    Desai, Rajendra
    Zugmaier, Gerhard
    Mergen, Noemi
    Cannell, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Treatment of locally recurrent, unresectable or metastatic breast cancer with AMG 706 plus paclitaxel or docetaxel: results from a phase 1b study
    de Boer, R.
    Kaufman, P.
    White, S.
    Mainwaring, P.
    Koczwara, B.
    Ye, Y.
    Sun, Y.
    Parson, M.
    Braun, A.
    Kotasek, D.
    EJC SUPPLEMENTS, 2008, 6 (07): : 222 - 222
  • [47] Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma
    Saad Z. Usmani
    Chatchada Karanes
    William I. Bensinger
    Anita D’Souza
    Noopur Raje
    Sascha A. Tuchman
    Douglas Sborov
    Jacob P. Laubach
    Giada Bianchi
    Dheepak Kanagavel
    Rao Saleem
    Franck Dubin
    Frank Campana
    Paul G. Richardson
    Leukemia, 2021, 35 : 3526 - 3533
  • [48] Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma
    Usmani, Saad Z.
    Karanes, Chatchada
    Bensinger, William I.
    D'Souza, Anita
    Raje, Noopur
    Tuchman, Sascha A.
    Sborov, Douglas
    Laubach, Jacob P.
    Bianchi, Giada
    Kanagavel, Dheepak
    Saleem, Rao
    Dubin, Franck
    Campana, Frank
    Richardson, Paul G.
    LEUKEMIA, 2021, 35 (12) : 3526 - 3533
  • [49] A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndrome
    Wei, Andrew H.
    Garcia, Jacqueline S.
    Borate, Uma
    Fong, Chun Yew
    Baer, Maria R.
    Nolte, Florian
    Peterlin, Pierre
    Jurcic, Joseph G.
    Garcia-Manero, Guillermo
    Hong, Wan-Jen
    Platzbecker, Uwe
    Odenike, Olatoyosi
    Dunbar, Martin
    Zhou, Ying
    Harb, Jason
    Tanwani, Poonam
    Wolff, Johannes E.
    Jacoby, Meagan
    BLOOD, 2019, 134
  • [50] Results of the Phase 1b Dose Escalation Study of OPB-111077, Decitabine, and Venetoclax for the Treatment of Newly Diagnosed or Relapsed/Refractory AML
    Wilde, Lindsay
    Martinez-Outschoorn, Ubaldo
    Palmisiano, Neil
    Keiffer, Gina
    Kasner, Margaret
    BLOOD, 2020, 136
12345